New Facility Expansion Allows Tandem Labs To Meet Increasing Demands For Drug Discovery And Development Services
West Trenton, NJ - Tandem Labs recently unveiled a new 9,000-square-foot facility at 370 Sullivan Street across the street from its existing West Trenton laboratory at 115 Silvia Street, New Jersey. The new addition increases the company's New Jersey operations to 23,000-square-feet. The West Trenton site is one of three for Tandem Labs in the United States, with the other two located in Salt Lake City, Utah and Woburn, Massachusetts.
The 370 Sullivan Street facility will house the administrative functions of the company's New Jersey operations, including data management, quality assurance and business development, allowing Tandem Labs to fully maximize the 14,000-square-foot 115 Silvia Street structure as a state-of-the-art laboratory space. Two significant efficiencies achieved by this expansion include a more extensive presence for the company's Biomarker and Immunoanalytical Division as well as a more sizeable sample receipt center. This expansion also supports the company's drug discovery and development activities by providing additional capacity and flexibility for the company's clients in the biotechnology and pharmaceutical industry.
Said Denis C.K. Lin, Ph.D., president and chief executive officer of Tandem Labs, "This expansion is an important milestone, demonstrating our continued growth and success in the field of contract pharmaceutical and biotechnology research. It also reaffirms our commitment to this region."
The New Jersey operation is designed specifically for GLP-compliant bioanalysis on LC/MS/MS and various Immunoanalytical platforms. The highly experienced technical staff combined with proximity to many pharmaceutical companies makes Tandem Labs' New Jersey site an ideal resource for comprehensive bioanalytical requirements and discovery services, including biomarker, cell-based assays, and Immunoanalytical services supporting the development and validation of new drugs.
As stated earlier, the company has an established presence in Utah and Massachusetts with a 24,000-square-foot facility and a 7,000-square-foot facility, respectively. The Salt Lake City location focuses primarily on GLP bioanalytical services while the Woburn location specializes in rapid, non-GLP discovery work.
SOURCE: Tandem Labs